galantamine and Parkinsonian Disorders

galantamine has been researched along with Parkinsonian Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H	1
Abbas, SF; Baqi, Y; Chrobak, JJ; Collins, LE; Galtieri, DJ; Leser, CE; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD	1
Edwards, K; Farlow, M; Hake, A; Hershey, L; Johnson, S; Lichter, D; Pasquier, F; Royall, D	1

Trials

1 trial(s) available for galantamine and Parkinsonian Disorders

Article	Year
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study. Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6 Topics: Aged; Aged, 80 and over; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Galantamine; Hallucinations; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Treatment Outcome	2007

Article

Year

Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.

Dementia and geriatric cognitive disorders, 2007, Volume: 23, Issue:6

Topics: Aged; Aged, 80 and over; Behavioral Symptoms; Cholinesterase Inhibitors; Dementia; Dose-Response Relationship, Drug; Female; Galantamine; Hallucinations; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Treatment Outcome

2007

Other Studies

2 other study(ies) available for galantamine and Parkinsonian Disorders

Article	Year
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model. Neuroscience research, 2008, Volume: 62, Issue:4 Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase	2008
Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:3 Topics: Alzheimer Disease; Animals; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Galantamine; Jaw; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tremor	2011

Article

Year

Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.

Neuroscience research, 2008, Volume: 62, Issue:4

Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase

2008

Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease.

Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:3

Topics: Alzheimer Disease; Animals; Cholinergic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Galantamine; Jaw; Male; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Treatment Outcome; Tremor

2011